Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis

Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis

Objective: A meta-analysis is conducted to evaluate the effectiveness and safety of bevacizumab in hereditary hemorrhagic telangiectasia (HHT) epistaxis.Method: Two researchers search PubMed, EMBASE and Web of Science databases from their inception until September 3th, 2023. The literature is read a...

Full description

Bibliographic Details
Main Authors: Huimin Chen, Zhiping Zhang, Xiaojuan Chen, Chaoyu Wang, Mingdi Chen, Huizhao Liao, Jinru Zhu, Zhenzhen Zheng, Riken Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Pharmacology
Subjects:
bevacizumab
hereditary hemorrhagic telangiectasia epistaxis
treatment
efficacy
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1089847/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1089847/full

Similar Items